Don't Just Read the News, Understand It.
Published loading...Updated

Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound

Summary by Bloomberg
Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players in the industry, Hims & Hers Health Inc.

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Bloomberg broke the news in United States on Tuesday, June 10, 2025.
Sources are mostly out of (0)